28041848|t|Spatiotemporal Control of Intracellular Phase Transitions Using Light-Activated optoDroplets
28041848|a|Phase transitions driven by intrinsically disordered protein regions (IDRs) have emerged as a ubiquitous mechanism for assembling liquid-like RNA/protein (RNP) bodies and other membrane-less organelles. However, a lack of tools to control intracellular phase transitions limits our ability to understand their role in cell physiology and disease. Here, we introduce an optogenetic platform that uses light to activate IDR -mediated phase transitions in living cells. We use this " optoDroplet " system to study condensed phases driven by the IDRs of various RNP body proteins, including FUS, DDX4, and HNRNPA1. Above a concentration threshold, these constructs undergo light-activated phase separation, forming spatiotemporally definable liquid optoDroplets. FUS optoDroplet assembly is fully reversible even after multiple activation cycles. However, cells driven deep within the phase boundary form solid-like gels that undergo aging into irreversible aggregates. This system can thus elucidate not only physiological phase transitions but also their link to pathological aggregates.
28041848	0	14	Spatiotemporal	T062	C3494293
28041848	26	39	Intracellular	T082	C0178719
28041848	40	57	Phase Transitions	T070	C1257888
28041848	64	92	Light-Activated optoDroplets	T062	C0035177
28041848	93	110	Phase transitions	T070	C1257888
28041848	121	161	intrinsically disordered protein regions	T116,T123	C3658247
28041848	163	167	IDRs	T116,T123	C3658247
28041848	187	207	ubiquitous mechanism	T044	C0678659
28041848	235	246	RNA/protein	T116,T123	C0035544
28041848	248	251	RNP	T116,T123	C0035544
28041848	253	259	bodies	T026	C1995017
28041848	270	294	membrane-less organelles	T026	C0029219
28041848	315	320	tools	UnknownType	C0541506
28041848	332	345	intracellular	T082	C0178719
28041848	346	363	phase transitions	T070	C1257888
28041848	411	426	cell physiology	T043	C0007613
28041848	431	438	disease	T047	C0012634
28041848	462	473	optogenetic	T063	C3494301
28041848	474	482	platform	T075	C1710360
28041848	502	510	activate	T052	C1879547
28041848	511	514	IDR	T116,T123	C3658247
28041848	525	542	phase transitions	T070	C1257888
28041848	546	552	living	T078	C0376558
28041848	553	558	cells	T025	C0007634
28041848	574	585	optoDroplet	T062	C0035177
28041848	588	594	system	T169	C0449913
28041848	598	603	study	T062	C2603343
28041848	604	613	condensed	T052	C0441655
28041848	614	620	phases	T079	C0205390
28041848	635	639	IDRs	T116,T123	C3658247
28041848	651	654	RNP	T116,T123	C0035544
28041848	655	659	body	T026	C1995017
28041848	660	668	proteins	T116,T123	C0033684
28041848	680	683	FUS	T116	C4043426
28041848	685	689	DDX4	T116,T126	C1432909
28041848	695	702	HNRNPA1	T116,T123	C1446980
28041848	712	725	concentration	T081	C1446561
28041848	726	735	threshold	T080	C0449864
28041848	762	794	light-activated phase separation	T067	C1522240
28041848	804	820	spatiotemporally	T062	C3494293
28041848	831	837	liquid	T167	C0302908
28041848	838	850	optoDroplets	T062	C0035177
28041848	852	855	FUS	T116	C4043426
28041848	856	867	optoDroplet	T062	C0035177
28041848	886	896	reversible	T169	C0205343
28041848	917	934	activation cycles	T079	C0001289
28041848	945	950	cells	T025	C0007634
28041848	974	979	phase	T079	C0205390
28041848	994	1009	solid-like gels	T122	C0017243
28041848	1047	1057	aggregates	T169	C0332621
28041848	1064	1070	system	T169	C0449913
28041848	1099	1112	physiological	T169	C0205463
28041848	1113	1130	phase transitions	T070	C1257888
28041848	1154	1166	pathological	T169	C1521733
28041848	1167	1177	aggregates	T169	C0332621